Himatsingka Seide Ltd vs Skybiotech Healthcare Limited Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 28, 2026

Key Highlights

The Latest Trading Price of Himatsingka Seide Ltd is ₹ 89.91 as of 25 Jun 15:30 . The P/E Ratio of Himatsingka Seide Ltd changed from 10.5 on March 2022 to 23.3 on March 2025 . This represents a CAGR of 22.05% over 4 yearsThe P/E Ratio of Skybiotech Healthcare Limited changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Himatsingka Seide Ltd changed from ₹ 1426 crore on March 2021 to ₹ 1771 crore on March 2025 . This represents a CAGR of 4.43% over 5 yearsThe Market Cap of Skybiotech Healthcare Limited changed from ₹ 31.33 crore on March 2025 to ₹ 31.33 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Himatsingka Seide Ltd for the Mar '26 is ₹ 721.68 crore as compare to the Dec '25 revenue of ₹ 637.26 crore. This represent the growth of 13.25% The revenue of Skybiotech Healthcare Limited for the Mar '26 is ₹ 1.98 crore as compare to the Dec '25 revenue of ₹ 1.04 crore. This represent the growth of 90.38% The ebitda of Himatsingka Seide Ltd for the Mar '26 is ₹ 154.17 crore as compare to the Dec '25 ebitda of ₹ 120.97 crore. This represent the growth of 27.44% The ebitda of Skybiotech Healthcare Limited for the Mar '26 is ₹ -0.73 crore as compare to the Dec '25 ebitda of ₹ -0.36 crore. This represent the growth of 102.78% The net profit of Himatsingka Seide Ltd changed from ₹ 20.56 crore to ₹ 1.73 crore over 8 quarters. This represents a CAGR of -70.99% The net profit of Skybiotech Healthcare Limited changed from ₹ 0.25 crore to ₹ -0.3 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Himatsingka Seide Ltd changed from 9.16 % on March 2021 to 2.14 % on March 2025 . This represents a CAGR of -25.23% over 5 yearsThe Dividend Payout of Skybiotech Healthcare Limited changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Himatsingka Seide Ltd

Himatsingka Seide Limited was incorporated on January 23, 1985 and was promoted by Ajoy Kumar Himatsingka and Dinesh Himatsingka.
Company is engaged in manufacturing of home textile products, mainly in bedding, drapery and upholstery products, made of cotton, silk, and blends.
Their products include silk/blended fabrics, spun silk/blended yarn, bed linen fabric and bed linen sets. The company operates through their spinning and weaving divisions.
Himatsingka Filati, the spinning division, was established in technical collaboration with Filati Buratti of Italy, which produces a wide range of regular and fancy 100% silk and silk blended yarns and the weaving division offers yarn dyed decorative, bridal and fashion fabrics.
The entire operation of winding, doubling, twisting, dyeing, weaving and finishing is integrated under one roof.

About Skybiotech Healthcare Limited

Skybiotech Healthcare Limited was initially incorporated as Kapil Cotex Limited on October 14, 1983.
The Company has altered a change in name with due approval from the Registrar of Companies to Skybiotech Healthcare Limited in 2025. he Company is involved in Spinning, weaving and finishing of textiles. During the concerned year, it did not get any revenue from its main objects.
However, it gives consultancy & assistance in selling the goods of foreign clients & earned brokerage/consultancy income.
It also deals in shares & Securities, where it earned capital gains & dividend income. Company has acquired 72.52% stake in M/s.
Skybiotech Lifescience Private Limited, making it a subsidiary of the Company in 2024.

FAQs for the comparison of Himatsingka Seide Ltd and Skybiotech Healthcare Limited

Which company has a larger market capitalization, Himatsingka Seide Ltd or Skybiotech Healthcare Limited?

Market cap of Himatsingka Seide Ltd is 1,130 Cr while Market cap of Skybiotech Healthcare Limited is 38 Cr

What are the key factors driving the stock performance of Himatsingka Seide Ltd and Skybiotech Healthcare Limited?

The stock performance of Himatsingka Seide Ltd and Skybiotech Healthcare Limited is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Himatsingka Seide Ltd and Skybiotech Healthcare Limited?

As of June 28, 2026, the Himatsingka Seide Ltd stock price is INR ₹89.91. On the other hand, Skybiotech Healthcare Limited stock price is INR ₹199.95.

How do dividend payouts of Himatsingka Seide Ltd and Skybiotech Healthcare Limited compare?

To compare the dividend payouts of Himatsingka Seide Ltd and Skybiotech Healthcare Limited, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.